TAG:
genetic test
“June 28, 2004 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XI No. 9 – June 28, 2004 Issue
There’s early evidence that health benefit costs for 2005 may only increase by a single digit percentage. Hewitt Associates is gathering data from 160 large companies for its annual healthcare cost survey. It reports that an average increase of 13.7% appears likely, compared to a 1…
IMPATH Has a Buyer: Genzyme Pays $215 Mil
By Robert Michel | From the Volume XI No. 4 – March 15, 2004 Issue
CEO SUMMARY: Two unexpected things happened in IMPATH’s Chapter 11 bankruptcy action. First, it attracted a buyer willing to pay the premium price of $215 million for its assets. Second, the buyer was not another laboratory company. Rather, it is a new entrant into the oncology diagnost…
“November 10, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 15 – November 10, 2003 Issue
Has the disappearance of much despised closed panel HMOs eased the financial woes of physicians? Apparently not, according to a recent study. Medical groups are losing money. Nationwide, the average loss-per-physician by medical groups was $3,977. In the 2003 survey, 25,784 physicians responded, a 26…
“September 29, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 13 – September 29, 2003 Issue
There was cautious optimism among lab industry leaders lobbying Congress to stop the proposed 20% co- payment for Part B laboratory testing services. It seems that, over the summer break, Iowa Senator Charles Grassley got a lesson in grass roots lobbying. At a number of town meetings, irate seniors s…
Are Two Blood Brothers Using Economic Clout?
By Robert Michel | From the Volume X No. 10 – July 28, 2003 Issue
CEO SUMMARY: Quest Diagnostics Incorporated and Laboratory Corporation of America now dominate the national marketplace for testing referred by physicians’ offices. Release of their second quarter earnings reports provides the first look at their performance following the acquisitions i…
“May 5, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 6 – May 5, 2003 Issue
There are rumors coming from the West Coast that government laboratory regulators are targeting at least one laboratory company for some significant violations. Because allegations of compliance violations by the government can severely damage a lab company’s reputation, there is a tight lid on infor…
Lab Director Takes a Stand On Patented Genetic Testing
By Robert Michel | From the Volume X No. 3 – March 3, 2003 Issue
THIS LETTER APPEARED in the mailbag after our special intelligence briefing on how genetics will transform healthcare and before our look at how high-priced specialty esoteric testing is causing budget headaches for regional labs. (See TDRs, December 30, 2002 and …
Jamaica Med Techs, Kaiser Permanente, Cytyc, Myriad Genetics, Bayer, CLMA
By Robert Michel | From the Volume X No. 2 – February 10, 2003 Issue
MEDICAL TECHNOLOGISTS IN JAMAICA STAGE WALK-OUT IN JANUARY LABORATORY TECHS ARE NOT KNOWN to be a radical component of the labor movement. But that doesn’t seem to be the case in Jamaica, where more than 80 of that country’s medical technologists walked off their jobs twice in January in…
Aetna, AmeriPath, DIANON, IMPATH, JCAHO
By Robert Michel | From the Volume IX No. 10 – July 15, 2002 Issue
AETNA RECOMMENDS PAYERS SUPPORT GENETIC SCREENING TESTS ALL LABORATORIANS SHOULD send a special note of thanks to Aetna Chairman and CEO John W. Rowe, M.D. for his recommendation that the health industry support the concept of genetic testing. He made these recommendations as part of speech…
Myriad Genetics, LabCorp, Abbott Labs, OraSure,TheraSense
By Robert Michel | From the Volume IX No. 9 – June 24, 2002 Issue
DIRECT-TO-CONSUMER ADS FROM MYRIAD GENETICS TO START THIS FALL FOLLOWING THE EXAMPLE of the pharmaceutical industry in using direct-to consumer advertising to build drug sales, Myriad Genetics, Inc. is about to launch an advertising campaign for its predictive genetics tests…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized